B-mode Ultrasound Imaging in Detecting Early Liver Cancer
Quantitative Ultrasound Spectroscopy to Early HCC
Sponsor: Stanford University
A NA clinical study on Cirrhosis and Early Hepatocellular Carcinoma, this trial is completed. The trial is conducted by Stanford University and has accumulated 10 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Sep 2021 — Jul 2024 [monthly]
Completed NA
Status: Suspended → Completed
-
Jan 2021 — Sep 2021 [monthly]
Suspended NA
-
Jul 2019 — Jan 2021 [monthly]
Suspended NA
▶ Show 5 earlier versions
-
Oct 2018 — Jul 2019 [monthly]
Suspended NA
Status: Completed → Suspended
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Oct 2017 — Jun 2018 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jul 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jan 2017 — Jul 2017 [monthly]
Recruiting NA
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .